Shares in Bruker BioSciences rose more than 9 percent this past week following an upgrade by investment bank UBS on its stock from 'neutral' to 'buy.' The firm's shares gained 7.8 percent the previous week on news that it would acquire affiliated company Bruker Optics (see BioCommerce Week 4/19/2006). PerkinElmer and Stratagene led decliners for the tracking period, falling 3.72 percent and 3.21 percent, respectively.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.